02-07-2025
Novo Nordisk, WeightWatchers expand collaboration
WW International (WGHTH) 'announced an expanded collaboration with Novo Nordisk (NVO), which includes increased access to authentic, FDA-approved Wegovy injection through WeightWatchers (WGHTQ) Clinic. As the only holistic platform focused on long-term weight health featuring the No. 1 doctor-recommended weight loss program included in the recently announced collaboration with Novo Nordisk, WeightWatchers continues to reinforce its role as the trusted leader in sustainable, science-backed weight care, and one of the few in the industry to publicly commit to prescribing only FDA-approved medications. As part of the collaboration, WeightWatchers Clinic members will benefit from a simplified prescription process via NovoCare Pharmacy. CenterWell Pharmacy, a seven-time MMIT Specialty Pharmacy Patient Choice Award winner for best-in-class customer satisfaction and commitment to patient care, serves as the dispensing pharmacy for the NovoCare program and will facilitate direct fulfillment and home delivery of Wegovy prescriptions for WeightWatchers Clinic members. In addition, WeightWatchers will enhance the member experience by providing integrated account access, bundled pricing opportunities, inventory visibility, and shipment tracking. Additionally, Novo Nordisk is offering a limited-time savings offer available to WeightWatchers Clinic members. Starting July 1, 2025, eligible cash-pay members can access Wegovy at a reduced price of $299 until July 31, 2025-a significant savings aimed at expanding access to clinically validated, FDA-regulated treatment options.'
